Pharmacokinetics (PK) of PF-02341066, a dual ALK/MET inhibitor after multiple oral doses to advanced cancer patients Meeting Abstract


Authors: Tan, W.; Wilner, K. D.; Bang, Y.; Kwak, E. L.; Maki, R. G.; Camidge, D. R.; Solomon, B. J.; Ou, S. I.; Salgia, R.; Clark, J. W.
Abstract Title: Pharmacokinetics (PK) of PF-02341066, a dual ALK/MET inhibitor after multiple oral doses to advanced cancer patients
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 228s
Language: English
ACCESSION: WOS:000208852003187
DOI: 10.1200/jco.2010.28.15_suppl.2596
PROVIDER: wos
Notes: Meeting Abstract: 2596 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Maki
    241 Maki